These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8182127)

  • 1. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.
    Kimble RB; Vannice JL; Bloedow DC; Thompson RC; Hopfer W; Kung VT; Brownfield C; Pacifici R
    J Clin Invest; 1994 May; 93(5):1959-67. PubMed ID: 8182127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
    Kimble RB; Matayoshi AB; Vannice JL; Kung VT; Williams C; Pacifici R
    Endocrinology; 1995 Jul; 136(7):3054-61. PubMed ID: 7789332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
    Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
    J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss.
    Kimble RB; Kitazawa R; Vannice JL; Pacifici R
    Calcif Tissue Int; 1994 Oct; 55(4):260-5. PubMed ID: 7820776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovariectomy-induced bone loss and the hematopoietic system.
    Kalu DN; Salerno E; Liu CC; Ferarro F; Arjmandi BN; Salih MA
    Bone Miner; 1993 Nov; 23(2):145-61. PubMed ID: 8305879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women.
    Abrahamsen B; Shalhoub V; Larson EK; Eriksen EF; Beck-Nielsen H; Marks SC
    Bone; 2000 Feb; 26(2):137-45. PubMed ID: 10678408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
    Vargas SJ; Naprta A; Lee SK; Kalinowski J; Kawaguchi H; Pilbeam CC; Raisz LG; Lorenzo JA
    J Bone Miner Res; 1996 Dec; 11(12):1926-34. PubMed ID: 8970895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo inhibition of localized bone resorption by human recombinant interleukin-1 receptor antagonist.
    Chole RA; Faddis BT; Tinling SP
    J Bone Miner Res; 1995 Feb; 10(2):281-4. PubMed ID: 7754808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cytokine levels in osteoporotic and normal women.
    Khosla S; Peterson JM; Egan K; Jones JD; Riggs BL
    J Clin Endocrinol Metab; 1994 Sep; 79(3):707-11. PubMed ID: 8077350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1.
    Guise TA; Garrett IR; Bonewald LF; Mundy GR
    J Bone Miner Res; 1993 May; 8(5):583-7. PubMed ID: 8511985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
    Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
    Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of osteoporosis with MMP inhibitors.
    Williams S; Barnes J; Wakisaka A; Ogasa H; Liang CT
    Ann N Y Acad Sci; 1999 Jun; 878():191-200. PubMed ID: 10415730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine.
    Keen RW; Woodford-Richens KL; Lanchbury JS; Spector TD
    Bone; 1998 Oct; 23(4):367-71. PubMed ID: 9763149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women.
    Han KO; Choi JT; Moon IG; Jeong MS; Yim CH; Chung HY; Jang HC; Yoon HK; Han IK
    Bone; 2002 Nov; 31(5):612-5. PubMed ID: 12477576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats.
    Beaudreuil J; Mbalaviele G; Cohen-Solal M; Morieux C; De Vernejoul MC; Orcel P
    J Bone Miner Res; 1995 Jun; 10(6):971-7. PubMed ID: 7572322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.